期刊文献+

乳腺癌组织VEGF-C表达临床意义的研究 被引量:1

Clinical significance of vascular endothelial growth factor C expression in breast carcinoma
原文传递
导出
摘要 目的:观察乳腺癌组织血管内皮生长因子-C(VEGF-C)的表达与淋巴结转移的相关性,明确VEGF-C能否作为乳腺癌淋巴结转移的标志。方法:采用免疫组织化学SP法对108例乳腺癌组织切片染色,观察VEGF-C的表达情况,评价VEGF-C的表达与淋巴结转移及其他临床病理因素的关系。结果:77例(71.3%)乳腺癌组织VEGF-C呈阳性表达,VEGF-C阳性表达与淋巴结转移有明显关系(χ2=6.245,P=0.044),同时与肿瘤大小亦有相关性,χ2=6.708,P=0.035。VEGF-C的表达与患者年龄、病理类型以及ER、PR、c-erbB-2的表达情况无明显相关。结论:VEGF-C对于乳腺癌淋巴结转移起重要作用,是乳腺癌重要的预后因子,而且与肿瘤大小呈正相关。 OBJECTIVE: To determine the feasibiligy of vas cular endothelial growth faetor-C (VEGF-C) could be as a tumor marker by detecting the relationship between VEGFC expression and lymph node status in breast cancer. METHODS: VEGF-C expression was assessed by immunohistochemistry in 108 cases of breast carcinomas. The relationship between expression of VEGF-C and lymph node status and clinicopathological features in breast cancer was analyzed. RESULTS: VEGF-C expression was i dentified in 77 cases (71.3 %). Positive VEGF-C was significantly correlated with lymph node metastasis (χ^2= 6. 245,P=0. 044) and tumor size (χ^2=6. 708, P=0. 035). There was no significant correlation between VEGF-C expression and the age of the patients, or hormone receptor status, or c erbB2 status. CONCLUSIONS: VEGF-C plays a crucial role in lymph node metastasis and may be a significant prognostic factor for long term survival in breast canc er. VEGF C also has positive association with tumor size.
出处 《中华肿瘤防治杂志》 CAS 2009年第3期197-199,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 免疫组织化学 肿瘤转移 血管内皮生长因子C breast neoplasms immunohistochemistry neoplasms metastasis, vascular endothelial growth faetor-C
  • 相关文献

参考文献9

  • 1Shimizu M, Saitoh Y, Itoh H. Immumohistochemical staining of Haras oncogene product in normal benign and malignant human breast tissue[J]. Hum Pathol, 1990,21(6) :607-612.
  • 2Schoppmann S F, Bayer G, Aumayr K, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer[J]. Ann Surg, 2004, 240(2) :306- 312.
  • 3Pytowski B, Goldman J, Persaud K, et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody[J]. J Natl Cancer Inst, 2005, 97:14-21.
  • 4Jimenez X, Lu D, Brennan L, et al. A recombinant, fully human, bispecifie antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3 [J]. MolCancer Ther, 2005, 4(3):427-434.
  • 5Ferrara N, Hillan K J, Gerber H P, et al. Discovery and development of bevaeizumab, an anti-VEGF antibody for treating cancer[J]. Nat Rev Drug Discov,2004,3(5):391-400.
  • 6Achen M G, McColl B K, Stacker S A. Focus on lymphangiogenesis in tumor metastasis[J]. Cancer Cell, 2005, 7(2): 121-127.
  • 7Yasushi Nakamura M D, Ph D, Hironao Yasuoka M D, et al. Clinicopathological Significance of Vascular Endothelial Growth Factor-C in Breast Carcinoma with Long-Term Follow Up [ J ]. Mod Pathol, 2003,16(4):309-314.
  • 8Stacker S A, Williams R A, Achen M G. Lymphangiogenic growth factors as markers of tumor metastasis[J1. APMIS, 2004, 112 (7-8) : 539-549.
  • 9Ueda M, Terai Y, Yamashita Y, et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas[J]. Int J Cancer, 2002, 98(3):335-343.

同被引文献12

  • 1Porter PL, Sage EH, Lane TF, et al. Distribution of SPARC innormal and neoplastic human tissue[J]. Histochem Cytochem,1995,43(8):791-800.
  • 2Alexandre C, Susan LC. Modulation of matrix remodeling bySPARC in neoplastic progression [ J]. Semin Cell Dev Biol,2010, 21 (1):55-65.
  • 3张雪梅,陈嘉薇,胡宏慧,等.乳腺浸润性导管癌中SPARC、KISS-1和KA11的表达和意义[D].上海:上海交通大学,2008.
  • 4Cheetham S,Tang MJ,Mesak F, et al. SPARC promoter hy-permethylation in colorectal cancers can be reversed by 5-Aza-2_deoxycytidine to increase SPARC expression and improve thera-py response[J]. Br J Cancer, 2008,98(11):1810-1819.
  • 5Barth PJ, Moll R,Ramaswamy A. Stromal remodeling andSPARC (secreted protein acid rich in cysteine) expression in in-vasive ductal carcinomas ofthe breast[JJ. Virchows Arch,2005,446(5):532-536.
  • 6Prada F,Benedetti LG, Bravo Al, et al. SPARC endogenouslevel, rather than fibroblast-produced SPARC or stroma reor-ganization induced by SPARC,is responsible for melanoma cell-growth[J]. Invest Dematol,2007,127(11) : 2618-2628.
  • 7孙红艳,伍治平,邹天宁,洪建普,梅卫国.乳腺癌组织COX-2和VEGF-C表达与淋巴转移的相关性研究[J].中华肿瘤防治杂志,2009,16(1):51-54. 被引量:6
  • 8李竹林,朱明才,董蒲江.直肠癌中VEGF-D和uPA的表达与侵袭转移的关系[J].中华内分泌外科杂志,2009,3(2):85-87. 被引量:4
  • 9谢良喜,张晓辉,杨丽萍.VEGF-C的表达对胃食管交界癌淋巴管生成影响及其预后意义[J].中华肿瘤防治杂志,2010,17(16):1285-1288. 被引量:6
  • 10夏红强,何建蓉.Ki-67、EGFR、HER-2和p53在乳腺癌中的表达及其相关性[J].临床肿瘤学杂志,2011,16(2):139-143. 被引量:47

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部